A bug in the resistance to EGFR inhibitors: is there a role for Mycoplasma and cytidine deaminase in reducing the activity of osimertinib in lung cancer patients?

Alessandro Leonetti, Daniela Carbone, Alessandro Gregori, Marcello Tiseo, Godefridus J. Peters, Dongmei Deng, Elisa Giovannetti*

*Corresponding author for this work

Research output: Contribution to journalLetterAcademicpeer-review

Original languageEnglish
JournalJournal of Cancer Research and Clinical Oncology
Early online date2021
Publication statusE-pub ahead of print - 2021

Cite this